Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua H Lambert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Urology|October 20, 2022
Editorial CommentWilliam C Reed, Joshua H Lambert, Rashid K Sayyid
Cancer Investigation|July 19, 2022
Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related SuspensionsRashid K Sayyid, Anthony Hiffa, Phillip Woodruff, et al.
Urologic Oncology|March 26, 2021
Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical heterogeneity and implications for active surveillance decisionRashid K Sayyid, William C Reed, John Z Benton, et al.
Urology|February 12, 2021
Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance PatientsRashid K Sayyid, Laurence Klotz, John Z Benton, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Urology|October 20, 2022
Editorial CommentWilliam C Reed, Joshua H Lambert, Rashid K Sayyid
Cancer Investigation|July 19, 2022
Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related SuspensionsRashid K Sayyid, Anthony Hiffa, Phillip Woodruff, et al.
Urologic Oncology|March 26, 2021
Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical heterogeneity and implications for active surveillance decisionRashid K Sayyid, William C Reed, John Z Benton, et al.
Urology|February 12, 2021
Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance PatientsRashid K Sayyid, Laurence Klotz, John Z Benton, et al.
Pageof 1